Gov. Ned Lamont and Health Commissioner Manisha Juthani have urged adult residents to get inoculated ahead of the holidays.
Moderna
More COVID vaccines are being wasted as demand drops
Nearly a third of all wasted COVID vaccine doses in CT were lost since the end of May.
The J&J vaccine: What we know, what we don’t know, and where we go from here
Officials ‘paused’ administration of the vaccine on Tuesday
Lamont: With thousands fewer J&J COVID vaccine doses, CT will have to make do for a time
Manufacturing problems will delay thousands of Johnson & Johnson COVID-19 vaccines from reaching Connecticut in the coming weeks.
With limited supply, Lamont asks for patience on COVID vaccine
Nearly 1.4 million Connecticut residents will be eligible for vaccination next, but the state only gets 45,000 doses a week.
Advisory group: People aged 65 to 74, those with underlying conditions should be part of next phase for COVID vaccine
News about expanding the vaccine came the same day Connecticut’s daily positivity rate jumped to 10.7%, the highest since spring.
Teachers, first responders, postal staff should be next in line for COVID vaccine, federal panel recommends
Connecticut is expected to get 63,300 doses of the Moderna vaccine this week, along with 24,375 doses from Pfizer.
With vaccine released and COVID infections down last weekend, Lamont urges vigilance
With the coronavirus vaccine’s release following a weekend of dropping infection rates, Gov. Ned Lamont urged residents to remain cautious.
First doses of COVID vaccine could be administered in CT in mid-December
The state is expected to get its first shipment of COVID vaccines as early as Dec. 14.
‘It has to do with trust:’ Outreach on COVID vaccine begins in communities of color
Longstanding health disparities have amplified during the pandemic, creating ‘heightened levels of mistrust.’
State’s vaccine panel weighs who should be first in line for COVID vaccine
The panel is analyzing who should receive the first doses of a coronavirus vaccine and devising strategies for public outreach.
Connecticut sends COVID-19 distribution plan to CDC
The proposal calls for a three-stage distribution plan, but complex logistics remain unresolved.
Doubts about COVID-19 vaccine have spurred calls for transparency from Pfizer, other pharmaceuticals
‘The trust is not there,’ said Yale cardiologist Harlan Krumholz.
COVID-19 vaccine makers seek diversity in clinical trials in Connecticut and elsewhere
While Blacks and Latinos are hardest hit by the coronavirus, they are wary of participating in vaccine trials.
Pfizer’s Groton site helped develop a COVID-19 vaccine. Now the question is, will it work?
Pfizer CEO Albert Bourla said he expects to know, by the end of October, ‘whether the product works or not.’